Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET

Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET

VADUZ, Liechtenstein, May 18, 2026 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2026 at 15:00 CET on May 22. The interim report for the first quarter (Q1 2026) will be published at 8:00 a.m. CET on the same day.

The presentation will be in English via webcast with teleconference:

If you wish to participate via webcast, please use the following link:        

• https://implantica.events.inderes.com/q1-report-2026

If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference.

• https://events.inderes.com/implantica/q1-report-2026/dial-in

Speakers:

• CEO Peter Forsell
• CFO Andreas Öhrnberg
• Chief Corporate Affairs Officer Nicole Pehrsson

For further information, please contact:
Nicole Pehrsson, Investor Relations
Telephone (CH): +41 43 505 20 57
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on May 18, 2026 at 09:00 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-presents-the-first-quarter--q1-2026--on-may-22-at-15-00-cet,c4349043

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/implantica-presents-the-first-quarter-q1-2026-on-may-22-at-1500-cet-302774468.html